PGY1 Pharmacy Residency Program

PGY1 Pharmacy Residency Program 

Residency Purpose Statement

PGY1 residency programs build upon Doctor of Pharmacy (PharmD) education and outcomes to develop pharmacist practitioners with knowledge, skills, and abilities as defined in the educational competency areas, goals, and objectives. Residents who successfully complete PGY1 residency programs will be skilled in diverse patient care, practice management, leadership, and education, and be prepared to provide patient care, seek board certification in pharmacotherapy (i.e.,BCPS), and pursue advanced education and training opportunities including postgraduate year two (PGY2) residencies.

Program Overview

The PGY-1 Pharmacy Residency is a 12-month program accredited by the American Society of Health-System Pharmacists, and was initiated in 1993 with one residency position. It has grown over the years to five positions. This residency offers the opportunity to learn and practice pharmaceutical care in an acute inpatient setting. Experiences are offered in management, critical care, cardiology, oncology, nutrition, transplant, pediatrics, general medicine, and informatics. One focus of our program is to customize the PGY1 learning experience to the resident. This is accomplished by having multiple elective rotations and tailoring the program to each residents’ individual goals.

Rotations

All clinical rotations are approximately 4 weeks duration and correspond with the calendar month.

Longitudinal Experiences

Selected Resident Publications

Quantifying Critical Care Pharmacist Interventions in COVID-19.
Pluenneke JC, Semler MW, Casey JD, et al.
Journal of Intensive Care Medicine Feb 2023

Identifying Predictors of Extubation on the day of Passing an SBT in Critically ill Adults.
Patel S, Stollings JL, Casey JD, et al.
J Intensive Care Med. 2023 Jun; 38(6):529-533.

5 verus 10 Units of Intravenous Insulin for Hyperkalemia in Patients with Moderate Renal Dysfunction.
Finder SN, McLaughlin LB, Dillon RC.
J Emerg Med. 2022 Mar;62(3):298-305.

Evaluation of healthcare-associated infection rates in patients with hematologic malignancies and stem cell transplantation during the coronavirus disease 2019 (COVID-19) pandemic. 
Bobbitt LJ, Satyanarayana G, Van Metre Baum L, Nebhan CA, Kassim AA, Gatwood KS
Antimicrobial Stewardship & Healthcare Epidemiology 2022:2(1):e11

The Efficacy and Safety of Methylnaltrexone for the Treatment of Postoperative Ileus. Am Surg
Beavers J, Orton L, Atchison A, et al.
2021 Oct 13. 31348211048825. doi: 10.1177/00031348211048825. Online ahead of print.

New-onset posttransplant diabetes mellitus after haploidentical hematopoietic cell transplantation with posttransplant cyclophosphamide
Mangan BL, Patel D, Chen H, Gatwood K, et al.
eJHaem 2020;1-5

Driving antimicrobial use improvement: attitudes of providers of adult hospital care on optimal attribution and feedback
Lines, TH, Nesbitt WJ, Nelson GE
Infection Control and Hospital Epidemiology 2018;39(8) : 983-985

Time to First Culture Positivity Among Critically Ill Adults with Methicillin-Resistant Staphylococcus aureus Growth in Respiratory or Blood Cultures
Melling PA, Noto MJ, Rice TW, et al. 
Annals of Pharmacotherapy 2019 Sept 22

International Analgesia, Sedation, and Delirium Practices: a prospective cohort study
Owen GD, Stollings JL, Rakhit S, et al.
Journal of Intensive Care 2019;7(25):3-7

Antimicrobial Exposure and the Risk of Delirium in Critically Ill Patients
Grahl JJ, Stollings JL, Rakhit S, Person AK, et al.
Critical Care 2018;22:337

Defining Incidence and Risk Factors for Catheter-Associated Bloodstream Infections in an Outpatient Adult Hematopoietic Cell Transplantation Program
McDonald MK, Culos KA, Gatwood KS, et al.
Biol Blood Marrow Transplant. 2018 (00);1-7

“Real-World” Application of Thrombolysis in Cardiac Arrest
Smith SE, Johnson DC.
J Pharm Pract. 2018 Sep 13

  Click here to see more resident publications

Program Details

Application Information

Number of Positions: Five
Residency starting date: June 17, 2024
Paid Time Off (PTO) including holidays: 16 days
Estimated stipend - approx. $54,101* info not verified

Application Requirements

Doctor of Pharmacy degree from an ACPE accredited degree program, CV, letter of intent, three letters of recommendation (minimum of two letters from clinical preceptors), transcripts for pharmacy coursework, licensure in Tennessee, and GPA greater than 3.25. Candidates from pass/fail pharmacy schools will be given full consideration.
The VUMC pharmacy residency program is NOT able to sponsor visas for pharmacy residents.

Submit application in PhORCAS application portal by January 2 deadline

Contact Information

email: pgy1pharmresidency@vumc.org
Kelli Rumbaugh, PharmD, BCPS, BCCCP, PGY1 Residency Program Director
Vanderbilt University Medical Center   Department of Pharmacy
1211 Medical Center Drive B131 VUH   Nashville, TN 37232-7610

Institutional Information

Private non-profit hospital/clinic | Teaching/Tertiary Model | Total Beds 1622
Professional Staff = 372 | Non-professional staff = 450